Literature DB >> 10359108

Antigen presentation by T cells versus professional antigen-presenting cells (APC): differential consequences for T cell activation and subsequent T cell-APC interactions.

L S Taams1, W van Eden, M H Wauben.   

Abstract

We compared the effects of antigen (Ag) presentation by T cells and professional antigen-presenting cells (APC) on T cell proliferation, cytokine production and surface molecule expression. Ag presentation by T cells (T-T presentation) induced an initial T cell activation phase as measured by proliferation and IL-2 production. These activated T cells became anergic upon antigenic restimulation by professional APC, as shown by a failure to proliferate or produce IL-2 or IFN-gamma. Interestingly, such T cells were not intrinsically defective in their signal transduction pathways since they did proliferate and produce cytokines upon restimulation with mitogenic stimuli. Flow cytometric analysis revealed a more profound TCR and CD3 down-regulation during T-T presentation than during APC-T presentation. However, no up-regulation of CD80, CD86, CD45RC and OX40 (CD134) was observed on T cells during T-T presentation or subsequent antigenic restimulation of anergic T cells in the presence of professional APC, whereas increased expression of these molecules was observed during professional APC-T presentation of non-anergic T cells. The impaired expression of co-stimulatory and activation molecules on T cells after T-T presentation of Ag might lead to altered interactions between T cells and professional APC upon antigenic restimulation. We propose that T cell anergy is a functional consequence of these altered T cell-APC interactions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10359108     DOI: 10.1002/(SICI)1521-4141(199905)29:05<1543::AID-IMMU1543>3.0.CO;2-R

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

Review 1.  The peripheral generation of CD4+ CD25+ regulatory T cells.

Authors:  Arne N Akbar; Leonie S Taams; Mike Salmon; Milica Vukmanovic-Stejic
Journal:  Immunology       Date:  2003-07       Impact factor: 7.397

2.  CD4(+) T cell-released exosomes inhibit CD8(+) cytotoxic T-lymphocyte responses and antitumor immunity.

Authors:  Haifeng Zhang; Yufeng Xie; Wei Li; Rajni Chibbar; Sidong Xiong; Jim Xiang
Journal:  Cell Mol Immunol       Date:  2010-12-13       Impact factor: 11.530

Review 3.  Cellular immunotherapy: antigen recognition is just the beginning.

Authors:  Daniel S Chen; Mark M Davis
Journal:  Springer Semin Immunopathol       Date:  2005-04-16

4.  A human-mouse chimeric model of obliterative bronchiolitis after lung transplantation.

Authors:  Jianmin Xue; Xuehai Zhu; M Patricia George; Michael M Myerburg; Michael W Stoner; Joseph W Pilewski; Steven R Duncan
Journal:  Am J Pathol       Date:  2011-06-12       Impact factor: 4.307

Review 5.  Tetherin/BST-2: Restriction Factor or Immunomodulator?

Authors:  Sam X Li; Bradley S Barrett; Kejun Guo; Mario L Santiago
Journal:  Curr HIV Res       Date:  2016       Impact factor: 1.581

Review 6.  Gene-modified dendritic cells for immunotherapy against cancer.

Authors:  Andreas Lundqvist; Pavel Pisa
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

Review 7.  CD4+ T Cell Subsets and Pathways to HIV Latency.

Authors:  Luis M Agosto; Andrew J Henderson
Journal:  AIDS Res Hum Retroviruses       Date:  2018-07-09       Impact factor: 2.205

Review 8.  The Murine CD137/CD137 Ligand Signalosome: A Signal Platform Generating Signal Complexity.

Authors:  Beom K Choi; Hyeon-Woo Lee
Journal:  Front Immunol       Date:  2020-12-10       Impact factor: 7.561

9.  HSP60 as a target of anti-ergotypic regulatory T cells.

Authors:  Francisco J Quintana; Avishai Mimran; Pnina Carmi; Felix Mor; Irun R Cohen
Journal:  PLoS One       Date:  2008-12-24       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.